Immediate Management: Add a Third Agent
You need to add a third antihypertensive medication immediately—specifically a thiazide-like diuretic such as chlorthalidone 12.5-25 mg daily or indapamide 1.25-2.5 mg daily. This patient has uncontrolled stage 2 hypertension despite being on maximum doses of an ACE inhibitor and calcium channel blocker, requiring escalation to triple therapy per current guidelines 1.
Why Add a Diuretic Now
The 2025 AHA/ACC guidelines explicitly recommend that antihypertensive therapy for resistant or uncontrolled hypertension should include the combination of an ACE inhibitor (or ARB), a calcium channel blocker, AND a diuretic 1. Your patient is already on:
- Lisinopril 20 mg (ACE inhibitor at moderate dose—can go up to 40 mg per FDA labeling 2)
- Amlodipine 10 mg (calcium channel blocker at maximum dose 3)
The blood pressure of 168/120 mmHg represents severe uncontrolled hypertension that requires urgent intensification. Adding a thiazide-like diuretic completes the foundational triple therapy regimen.
Preferred Diuretic Choice
Chlorthalidone or indapamide are superior to hydrochlorothiazide (HCTZ). The guidelines specifically note that replacing thiazide-type diuretics like HCTZ with thiazide-like diuretics (chlorthalidone and indapamide) may offer additional blood pressure reduction and cardiovascular protection, particularly in patients with previous MI or stroke 1.
Consider Increasing Lisinopril Dose
While adding the diuretic, you could also increase lisinopril from 20 mg to 40 mg daily. The FDA labeling indicates that lisinopril doses up to 80 mg daily have been studied in hypertension, though 20-40 mg is the typical therapeutic range 2. However, the priority is adding the third drug class (diuretic) rather than simply increasing the ACE inhibitor dose.
If Still Uncontrolled: Fourth Agent
If blood pressure remains above goal after 2-4 weeks on triple therapy (ACE inhibitor + calcium channel blocker + diuretic), add spironolactone 25-50 mg daily as the fourth agent. The guidelines emphasize that spironolactone is the preferred fourth-line agent for resistant hypertension, reducing 24-hour systolic BP by 6.6-8.7 mmHg compared to placebo in patients with eGFR ≥45 mL/min/1.73 m² 1. This was superior to adding doxazosin or bisoprolol.
Important caveat: Monitor potassium levels closely when combining an ACE inhibitor with spironolactone, as 4-40% of patients cannot tolerate spironolactone due to hyperkalemia or antiandrogenic side effects 1.
Essential Workup Before Escalating
Before adding medications, screen for:
- Secondary hypertension causes: Primary aldosteronism, obstructive sleep apnea, renal parenchymal disease, and renovascular disease are more common in resistant hypertension 1
- Medication interference: NSAIDs, nasal decongestants, and other over-the-counter medications can elevate BP or interfere with antihypertensive efficacy—approximately 20% of hypertensive adults use these 1
- Medication adherence: Confirm the patient is actually taking the prescribed medications
- White coat hypertension: Consider 24-hour ambulatory BP monitoring to confirm true uncontrolled hypertension 4
Timeline and Monitoring
- Add the diuretic immediately
- Reassess BP in 1-2 weeks (can titrate more rapidly if clinically warranted with frequent assessment 3)
- If still uncontrolled after optimizing triple therapy, add spironolactone
- Check basic metabolic panel within 1-2 weeks after adding diuretic or spironolactone to monitor potassium and renal function
Renal Denervation: Not Appropriate Yet
Renal denervation (RDN) may be considered only after the patient has failed optimal doses of 4+ antihypertensive medications (ACE inhibitor/ARB + calcium channel blocker + thiazide-like diuretic + mineralocorticoid receptor antagonist) or cannot tolerate these medications 1, 4. This patient hasn't even tried triple therapy yet, so RDN is premature.